"More than business, it's life," says Paula Scanapieco talking about RDC 660 and international logistics

Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics

Published on 08/29/2025

"Mais que negócio, é vida”, diz Paula Scanapieco fala sobre a RDC 660 e a logística internacional

Paula Scanapieco explains the role of RDC 660 in access to medical cannabis | Photo: Sechat

In the most recent episode of Deusa Cast, a podcast from Portal Sechat, three experts discussed the current scenario of medical cannabis in Brazil. The conversation covered regulatory advances, legal challenges, and prospects for the future, bringing together Larissa Meneghel, a lawyer specializing in health law and former Anvisa civil servant; Juliana Sousa, a lawyer practicing in customs and criminal law; and Paula Scanapieco, commercial manager at Mile Express, a company specialized in international logistics of cannabis-based products.


In this excerpt, we highlight Paula's comments on RDC 660, an Anvisa regulation that represents one of the main gateways to access cannabis medications in the country.


RDC 660 and its importance for patients


According to a survey by Kaya Mind, around 670,000 Brazilian patients are undergoing treatment with cannabis-based products. Most of them use imported medications via RDC 660, while others access them through RDC 327, associations, or judicial actions.


For Paula Scanapieco, the resolution plays an essential role: "RDC 660 has opened a loophole for us to expressly bring medications from other countries and help so many people," she states.


The role of international logistics in medical cannabis


Mile Express is directly involved in the transportation and release of these medications, ensuring they reach patients safely and legally. Paula explains that 90% of imports come from the United States, but there are also products coming from Europe, Colombia, and Uruguay.


The process is meticulous: from collecting the medication in the country of origin, through personalized preparation for each patient, with a medical prescription and Anvisa authorization, to the final delivery in any city in Brazil.


More than business: a commitment to life


For Paula, the work is not only commercial but also human: "International logistics today is the right arm for imported medication to reach the hands of patients who depend on it to live better." 


She emphasizes that, although the market is still in the development phase, serious partnerships between companies and logistics operators have already made a concrete difference in the lives of thousands of Brazilians.


Watch the full episode of Deusa Cast on our Youtube channel to check out this and other discussions about the future of medical cannabis in Brazil.

Watch the interview segment: